scholarly journals Oncologic outcome of marginal mandibulectomy in squamous cell carcinoma of the lower gingiva

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Wei Du ◽  
Qigen Fang ◽  
Yao Wu ◽  
Junfu Wu ◽  
Xu Zhang
2015 ◽  
Vol 193 (2) ◽  
pp. 451-456 ◽  
Author(s):  
Ramy F. Youssef ◽  
Friedrich-Carl von Rundstedt ◽  
Payal Kapur ◽  
Ahmed Mosbah ◽  
Hassan Abol-Enein ◽  
...  

2021 ◽  
pp. 194338752110150
Author(s):  
Atsushi Shudo

Study Design: Technical note. Objective: Marginal mandibulectomy is a surgical procedure for treatment of mandibular gingival tumors. The intraoral approach to the posterior region of the mandible for marginal mandibulectomy is difficult due to limited access and operating field visibility; the conventional surgical procedure may require some skin incisions. This report discusses the effectiveness of endoscopic assistance in marginal mandibulectomy. Methods: This article describes endoscopically assisted marginal mandibulectomy using an intraoral approach alone for squamous cell carcinoma of the posterior mandibular gingiva. Results: The advantages of this surgical method are twofold: (1) superior visibility to the lower edge of the mandible without any skin incision; and (2) safe surgical confirmation of important anatomy on the buccolingual side (e.g., mental foramen, lingual nerve, mandibular foramen, and neurovascular bundle). This minimally invasive approach without any skin incision, as well as the superior visibility of the operating field, are important advantages of endoscopically assisted marginal mandibulectomy that cannot be obtained by other surgical methods. Conclusions: Endoscopically assisted marginal mandibulectomy using an intraoral approach alone may be useful because it avoids damage to facial skin and improves safety by employing an enlarged bright field.


2016 ◽  
Vol 28 (1) ◽  
pp. 5-9
Author(s):  
Hidetoshi Matsui ◽  
Shigemichi Iwae ◽  
Yuji Hirayama ◽  
Koichiro Yonezawa ◽  
Takuji Hayashi ◽  
...  

2020 ◽  
Vol 162 (3) ◽  
pp. 267-268 ◽  
Author(s):  
Daniel W. Scholfield ◽  
Dorothy M. Gujral ◽  
Zaid Awad

The improved survival in patients with HPV-positive (human papilloma virus) oropharyngeal squamous cell carcinoma as compared with HPV-negative disease calls for treatment that preserves quality of life, particularly a functional swallow. There are several trials currently assessing treatment de-escalation in terms of less invasive transoral robotic surgery, reduced-dose radiotherapy, and omission of chemotherapy in this disease cohort. It is important for head and neck oncology surgeons to stay abreast of developments in this area to offer their patients the most up-to-date treatment and consider recruiting patients to trials at their institutions. For this purpose, we provide a summary of current trials and associated challenges in managing a disease with fast-evolving treatment algorithms.


Sign in / Sign up

Export Citation Format

Share Document